Join to View Full Profile
600 N Wolfe StCmsc-800Baltimore, MD 21287
Phone+1 410-644-5055
Fax+1 410-955-0028
Are you Dr. Fitzhugh?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Courtney Fitzhugh, MD is a pediatric hematologist/oncologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and North Carolina.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2006 - 2009
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
Duke University HospitalResidency, Internal Medicine/Pediatrics, 2001 - 2005
University of California San Francisco School of MedicineClass of 2001
Certifications & Licensure
MD State Medical License 2005 - 2026
NC State Medical License 2001 - 2005
American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Recipient Cells Are the Source of Hematologic Malignancies After Graft Failure and Mixed Chimerism in Adults With SCD.Mohamed A E Ali, Emily M Limerick, Matthew M Hsieh, Kalpana Upadhyaya, Xin Xu
American Journal of Hematology. 2025-05-01 - Reply to Holbert and Fraidenburg: Not to Be Forgotten. Pulmonary Vascular Effects of Nonmyeloablative Hematopoietic Cell Transplant for Sickle Cell Disease.A Parker Ruhl, Emily M Limerick, Amisha V Barochia, Courtney D Fitzhugh, Matthew M Hsieh
Annals of the American Thoracic Society. 2025-04-01 - A machine learning-based workflow for predicting transplant outcomes in patients with sickle cell disease.Haiou Li, Vandana Sachdev, Xin Tian, My-Le Nguyen, Matthew Hsieh
British Journal of Haematology. 2025-03-01
Press Mentions
ASH: Consider Marrow Transplant for Sickle Cell KidsDecember 8th, 2019
Ongoing Research Aims to Improve Transplant Outcomes in Sickle CellSeptember 26th, 2019
Sickle Cell Disease: No Longer the Road Less TravelledDecember 4th, 2018- Join now to see all
Grant Support
- Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell diseaseVANDERBILT UNIVERSITY MEDICAL CENTER2021–2026
